Rotarin effect on sore throat in patients with bacterial and allergic sore throats
Phase 3
- Conditions
- Patients with bacterial or allergic sore throat.
- Registration Number
- IRCT20140804018677N3
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Diagnosis of bacterial and allergic diseases by a physician
Aged 18-65 years
Exclusion Criteria
Pregnancy and lactation
Patients' reluctance to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The severity of the pain. Timepoint: baseline and end of study. Method of measurement: Quality of Life Questionnaire.;The effect of disease severity on daily activity. Timepoint: baseline and end of study. Method of measurement: Quality of Life Questionnaire.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What is the molecular mechanism of Rotarin in alleviating bacterial and allergic sore throat symptoms?
How does Rotarin's efficacy compare to standard-of-care treatments for bacterial and allergic sore throats?
Are there specific biomarkers that predict response to Rotarin in bacterial versus allergic sore throat patients?
What are the potential adverse events associated with Rotarin use in sore throat patients and their management strategies?
What are the current therapeutic alternatives to Rotarin for managing bacterial and allergic sore throat symptoms?